Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 29, 2012 | March 02, 2012 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | November 19, 2021 | November 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 29, 2012 · Filed March 02, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 144,311 |
Ending reported balance
After 2012-03-01 transaction · row 24
24 source rows · reconciled sequenceRow 1 · 2012-02-29 · Sale · Disposed 4,900 · Balance 220,896 Row 2 · 2012-02-29 · Sale · Disposed 5,750 · Balance 215,146 Row 3 · 2012-02-29 · Sale · Disposed 700 · Balance 214,446 Row 4 · 2012-02-29 · Sale · Disposed 4,115 · Balance 210,331 Row 5 · 2012-02-29 · Sale · Disposed 200 · Balance 210,131 Row 6 · 2012-02-29 · Sale · Disposed 15,135 · Balance 194,996 Row 7 · 2012-02-29 · Sale · Disposed 12,318 · Balance 182,678 Row 8 · 2012-02-29 · Sale · Disposed 2,800 · Balance 179,878 Row 9 · 2012-02-29 · Sale · Disposed 2,300 · Balance 177,578 Row 10 · 2012-02-29 · Sale · Disposed 4,403 · Balance 173,175 Row 11 · 2012-02-29 · Sale · Disposed 200 · Balance 172,975 Row 12 · 2012-02-29 · Sale · Disposed 3,697 · Balance 169,278 Row 13 · 2012-02-29 · Sale · Disposed 2,200 · Balance 167,078 Row 14 · 2012-02-29 · Sale · Disposed 100 · Balance 166,978 Row 15 · 2012-02-29 · Sale · Disposed 1,560 · Balance 165,418 Row 16 · 2012-02-29 · Sale · Disposed 100 · Balance 165,318 Row 17 · 2012-02-29 · Sale · Disposed 100 · Balance 165,218 Row 18 · 2012-02-29 · Sale · Disposed 4,300 · Balance 160,918 Row 19 · 2012-02-29 · Sale · Disposed 700 · Balance 160,218 Row 20 · 2012-02-29 · Sale · Disposed 907 · Balance 159,311 Row 21 · 2012-03-01 · Sale · Disposed 3,737 · Balance 155,574 Row 22 · 2012-03-01 · Sale · Disposed 7,000 · Balance 148,574 Row 23 · 2012-03-01 · Sale · Disposed 100 · Balance 148,474 Row 24 · 2012-03-01 · Sale · Disposed 4,163 · Balance 144,311 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 6,660 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 25
Holding and transaction disclosures are not merged.
1 source rowRow 25 · Balance 6,660 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife | 20,400 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 26
Holding and transaction disclosures are not merged.
1 source rowRow 26 · Balance 20,400 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 27
Holding and transaction disclosures are not merged.
1 source rowRow 27 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 28
Holding and transaction disclosures are not merged.
1 source rowRow 28 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012.
F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date November 19, 2021 · Filed November 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 26,123 |
Reported balance
After 2021-11-19 transaction · row 1
1 source rowRow 1 · 2021-11-19 · Grant · Acquired 4,271 · Balance 26,123 F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2009 Filed Jul 23, 2010 22:04 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-10-011860 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 50 F1 · shares: The Form 4 originally filed by the reporting person on December 23, 2009, is hereby amended to show the receipt by two of his daughters of a gift of 50 shares each. F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his daughters. Read SEC document |
| September 04, 2009 Filed Oct 2, 2009 20:05 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-09-014045 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,494 Read SEC document |
| May 01, 2009 Filed May 4, 2009 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,413 | $41.85 | $59,134.05 |
DisclosureSEC source: 0001104659-09-029083 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,554 Read SEC document |
| April 20, 2009 Filed Apr 22, 2009 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $44.21 | $48,631.00 |
DisclosureSEC source: 0001104659-09-025538 · a4.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,967 Read SEC document |
| April 20, 2009 Filed Apr 22, 2009 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,700 | $44.20 | $251,940.00 |
DisclosureSEC source: 0001104659-09-025538 · a4.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,067 Read SEC document |
| April 20, 2009 Filed Apr 22, 2009 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $44.20 | $13,258.50 |
DisclosureSEC source: 0001104659-09-025538 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,767 Read SEC document |
| April 20, 2009 Filed Apr 22, 2009 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 13,700 | $44.19 | $605,403.00 |
DisclosureSEC source: 0001104659-09-025538 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,067 Read SEC document |
| April 20, 2009 Filed Apr 22, 2009 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $44.18 | $132,540.00 |
DisclosureSEC source: 0001104659-09-025538 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,767 Read SEC document |
| April 20, 2009 Filed Apr 22, 2009 23:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $44.17 | $53,004.00 |
DisclosureSEC source: 0001104659-09-025538 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,767 Read SEC document |
| February 27, 2009 Filed Mar 3, 2009 16:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,317 | $50.58 | $268,933.86 |
DisclosureSEC source: 0001104659-09-013730 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,967 Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 38,700 | $0.00 Strike: $54.14 | $0.00 |
DisclosureSEC source: 0001104659-09-011802 · a4.xml · derivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,700 Underlying: Common shares · 38,700 shares Expires 2019-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,900 on 02/20/2010, 12,900 on 02/20/2011, and 12,900 on 02/20/2012. Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 27,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-011802 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,284 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2009 Filed Feb 19, 2009 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 584 | $54.35 | $31,741.57 |
DisclosureSEC source: 0001104659-09-010782 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,084 Read SEC document |
| February 17, 2009 Filed Feb 19, 2009 21:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,937 | $54.94 | $106,418.78 |
DisclosureSEC source: 0001104659-09-010782 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,668 Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,604 | $0.00 Strike: $53.24 | $0.00 |
DisclosureSEC source: 0001104659-09-005789 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 10,604 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-005789 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,605 Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,300 | $55.27 | $182,391.00 |
DisclosureSEC source: 0001104659-09-005789 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,655 Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,304 | $55.28 | $403,765.12 |
DisclosureSEC source: 0001104659-09-005789 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,955 Read SEC document |
| January 29, 2009 Filed Feb 3, 2009 00:29 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,604 | $53.24 | $564,556.96 |
DisclosureSEC source: 0001104659-09-005789 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2008 Filed Dec 31, 2008 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,260 | $52.51 | $66,162.60 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,655 Read SEC document |
| November 12, 2008 Filed Dec 31, 2008 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,915 Read SEC document |
| November 12, 2008 Filed Dec 31, 2008 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,935 Read SEC document |
| August 18, 2008 Filed Dec 31, 2008 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,035 Read SEC document |
| August 18, 2008 Filed Dec 31, 2008 22:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-079128 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,055 Read SEC document |
| May 01, 2008 Filed May 5, 2008 23:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 10,000 | $53.24 | $532,400.00 |
DisclosureSEC source: 0001104659-08-030001 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,075 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| April 23, 2008 Filed May 5, 2008 23:23 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-08-030001 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,075 Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 21,776 | $0.00 Strike: $55.66 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,776 Underlying: Common Shares · 21,776 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 24,764 | $0.00 Strike: $55.66 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,764 Underlying: Common Shares · 24,764 shares Expires 2009-03-31 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 28,664 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 28,664 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 28,197 | $0.00 Strike: $43.98 | $0.00 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 28,197 shares Expires 2009-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 46,540 | $55.66 | $2,590,416.40 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,125 Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 28,664 | $32.61 | $934,764.57 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 28,197 | $43.98 | $1,240,180.19 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2008 Filed Mar 26, 2008 20:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,321 | $55.41 | $571,896.93 |
DisclosureSEC source: 0001104659-08-019955 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,804 Read SEC document |
| March 19, 2008 Filed Mar 21, 2008 15:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,157 | $55.00 | $63,635.00 |
DisclosureSEC source: 0001104659-08-019002 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,125 Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 10,604 | $0.00 Strike: $53.24 | $0.00 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,604 Underlying: Common shares · 10,604 shares Expires 2009-02-11 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 12,236 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 12,236 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,217 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,217 shares Expires 2008-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 10,604 | $53.24 | $564,556.96 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,282 Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 12,236 | $42.50 | $520,003.08 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,217 | $52.95 | $64,443.80 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,650 Read SEC document |
| March 05, 2008 Filed Mar 7, 2008 00:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,217 | $52.66 | $64,087.22 |
DisclosureSEC source: 0001104659-08-015962 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2008 Filed Mar 5, 2008 01:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,402 | $54.22 | $130,236.44 |
DisclosureSEC source: 0001104659-08-015220 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,650 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 818 | $56.05 | $45,848.90 |
DisclosureSEC source: 0001104659-08-011839 · a4.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,052 Read SEC document |
| February 18, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 746 | $55.55 | $41,440.30 |
DisclosureSEC source: 0001104659-08-011839 · a4.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,870 Read SEC document |
| February 17, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,865 | $55.55 | $103,600.75 |
DisclosureSEC source: 0001104659-08-011839 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,616 Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 78,700 | $0.00 Strike: $55.56 | $0.00 |
DisclosureSEC source: 0001104659-08-011839 · a4.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,700 Underlying: Common shares · 78,700 shares Expires 2018-02-14 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,234 on 02/15/2009, 26,233 on 02/15/2010, and 26,233 on 02/15/2011. Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 19,700 | $55.56 | $1,094,532.00 |
DisclosureSEC source: 0001104659-08-011839 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,481 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,842 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · derivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,842 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,902 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-08-009510 · a4.xml · derivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,902 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.